These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31056860)

  • 21. Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System.
    Kinoshita M; Higashihara E; Kawano H; Higashiyama R; Koga D; Fukui T; Gondo N; Oka T; Kawahara K; Rigo K; Hague T; Katsuragi K; Sudo K; Takeshi M; Horie S; Nutahara K
    PLoS One; 2016; 11(11):e0166288. PubMed ID: 27835667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants.
    Raj S; Singh RG; Das P
    Mutat Res; 2020; 821():111718. PubMed ID: 32823016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease.
    Liu B; Chen SC; Yang YM; Yan K; Qian YQ; Zhang JY; Hu YT; Dong MY; Jin F; Huang HF; Xu CM
    Sci Rep; 2015 Dec; 5():17468. PubMed ID: 26632257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 28 novel mutations identified from 33 Chinese patients with cilia-related kidney disorders.
    Liang N; Jiang X; Zeng L; Li Z; Liang D; Wu L
    Clin Chim Acta; 2020 Feb; 501():207-215. PubMed ID: 31730820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients.
    Mochizuki T; Teraoka A; Akagawa H; Makabe S; Akihisa T; Sato M; Kataoka H; Mitobe M; Furukawa T; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2019 Aug; 23(8):1022-1030. PubMed ID: 30989420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Presumed Synonymous Mutation of PKD2 Caused Autosomal Dominant Polycystic Kidney Disease in a Chinese Family.
    Deng LX; Yang Y; Yang J; Zhou LW; Wang K; Zhou JH
    Curr Med Sci; 2021 Oct; 41(5):1029-1036. PubMed ID: 34542828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenicity analysis of novel variations in Chinese Han patients with polycystic kidney disease.
    Fang Z; Xu S; Wang Y; Sun L; Feng Y; Guo Y; Li H; Jiang W
    Gene; 2017 Aug; 626():433-441. PubMed ID: 28578020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations.
    Cornec-Le Gall E; Chebib FT; Madsen CD; Senum SR; Heyer CM; Lanpher BC; Patterson MC; Albright RC; Yu AS; Torres VE; ; Harris PC
    Am J Kidney Dis; 2018 Aug; 72(2):302-308. PubMed ID: 29395486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel PKD1 Mutations in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Kim H; Kim HH; Chang CL; Song SH; Kim N
    Lab Med; 2021 Mar; 52(2):174-180. PubMed ID: 32816041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing the clinical outcome of preimplantation genetic testing for polycystic kidney disease.
    Berckmoes V; Verdyck P; De Becker P; De Vos A; Verheyen G; Van der Niepen P; Verpoest W; Liebaers I; Bonduelle M; Keymolen K; De Rycke M
    Hum Reprod; 2019 May; 34(5):949-958. PubMed ID: 30927425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new PKD1 mutation discovered in a Chinese family with autosomal polycystic kidney disease.
    Wang Z; Wang Y; Xiong J
    Kidney Blood Press Res; 2014; 39(1):1-8. PubMed ID: 24821069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease.
    Ali H; Al-Mulla F; Hussain N; Naim M; Asbeutah AM; AlSahow A; Abu-Farha M; Abubaker J; Al Madhoun A; Ahmad S; Harris PC
    Sci Rep; 2019 Mar; 9(1):4141. PubMed ID: 30858458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
    Senum SR; Li YSM; Benson KA; Joli G; Olinger E; Lavu S; Madsen CD; Gregory AV; Neatu R; Kline TL; Audrézet MP; Outeda P; Nau CB; Meijer E; Ali H; Steinman TI; Mrug M; Phelan PJ; Watnick TJ; Peters DJM; Ong ACM; Conlon PJ; Perrone RD; Cornec-Le Gall E; Hogan MC; Torres VE; Sayer JA; ; Harris PC
    Am J Hum Genet; 2022 Jan; 109(1):136-156. PubMed ID: 34890546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-Clinical Correlations in Polycystic Kidney Disease with No Apparent Family History.
    Sekine A; Fujimaru T; Hoshino J; Suwabe T; Oguro M; Mizuno H; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y
    Am J Nephrol; 2019; 49(3):233-240. PubMed ID: 30820006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matching clinical and genetic diagnoses in autosomal dominant polycystic kidney disease reveals novel phenocopies and potential candidate genes.
    Schönauer R; Baatz S; Nemitz-Kliemchen M; Frank V; Petzold F; Sewerin S; Popp B; Münch J; Neuber S; Bergmann C; Halbritter J
    Genet Med; 2020 Aug; 22(8):1374-1383. PubMed ID: 32398770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetics and genetic counseling].
    Izzi C; Liut F; Dallera N; Mazza C; Magistroni R; Savoldi G; Scolari F
    G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.
    Rossetti S; Hopp K; Sikkink RA; Sundsbak JL; Lee YK; Kubly V; Eckloff BW; Ward CJ; Winearls CG; Torres VE; Harris PC
    J Am Soc Nephrol; 2012 May; 23(5):915-33. PubMed ID: 22383692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biallelic inheritance of hypomorphic PKD1 variants is highly prevalent in very early onset polycystic kidney disease.
    Durkie M; Chong J; Valluru MK; Harris PC; Ong ACM
    Genet Med; 2021 Apr; 23(4):689-697. PubMed ID: 33168999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.